SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-98-000085
Filing Date
1998-12-02
Accepted
1998-12-02 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO SCHEDULE 13D SC 13D/A 76160
  Complete submission text file 0001012168-98-000085.txt   78879
Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142466912
ALLERGAN SPECIALTY THERAPEUTICS INC (Subject) CIK: 0001049711 (see all company filings)

IRS No.: 330779207 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53925 | Film No.: 98762885
SIC: 2834 Pharmaceutical Preparations